ArticleBMC oral health2026
Computational pathology-based artificial intelligence platform for the identification of common oral potentially malignant disorders.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesOral potentially malignant disorders (OPMDs) refer to a group of significant precursor lesions for oral squamous cell carcinoma (OSCC). Early differential diagnosis of its subtypes including oral leukoplakia (OLK), oral lichen planus (OLP) and oral submucous fibrosis (OSF) is crucial for timely prevention and management of OSCC. The diverse clinical features of aforementioned conditions render clinical diagnosis challenging. To facilitate accurate and efficient diagnosis, this study aimed to construct a digital pathology-based artificial intelligence (AI) platform based on a sample of 1080 cases. MATERIALS AND
methodsFour deep learning models–Twins-SVT, ResNet18, ResNet50, and Inception_v3–were employed for patch-level analysis. The AI platform was developed by fusing deep learning-derived predictive features with multiple machine learning algorithms.
resultsThe AI platform developed in this study exhibited good diagnostic performance, with the diagnostic area under the receiver operating characteristic curve of 0.870 (95% CI: 0.827–0.913), 0.810 (95% CI: 0.751–0.870), and 0.833 (95% CI: 0.770–0.897) for OLK, OLP, and OSF, respectively. In addition, this study investigated the correlation between deep learning-derived AI features and pathological findings, demonstrating excellent interpretability of AI in pathology.
conclusionsIn this study, a robust AI platform was developed for differential diagnosis of OLK, OLP and OSF. Our research supports the feasibility of using deep learning methods to classify common OPMDs based on whole slide images.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.